Early-stage comparative effectiveness: Randomized controlled trial with histamine inverse agonist MK-7288 in excessive daytime sleepiness patients
Article first published online: 4 OCT 2013
© 2013, The American College of Clinical Pharmacology
The Journal of Clinical Pharmacology
Volume 53, Issue 12, pages 1294–1302, December 2013
How to Cite
Sun, H., MacLeod, C., Mostoller, K., Mahon, C., Han, L., Renger, J. J., Ma, J., Brown, K. R., Schulz, V., Kay, G. G., Herring, W. J., Lines, C., Rosen, L. B., Murphy, M. G. and Wagner, J. A. (2013), Early-stage comparative effectiveness: Randomized controlled trial with histamine inverse agonist MK-7288 in excessive daytime sleepiness patients. Journal of Clinical Pharma, 53: 1294–1302. doi: 10.1002/jcph.182
- Issue published online: 14 NOV 2013
- Article first published online: 4 OCT 2013
- Manuscript Accepted: 10 SEP 2013
- Manuscript Received: 28 MAR 2013
Additional supporting information may be found in the online version of this article at the publisher's web-site.
|jcph182-sm-0001-SuppData-S1.pdf||1048K||Data S1. Study protocol.|
|jcph182-sm-0001-SuppData-S2.doc||107K||Table S1. Summary of Adverse Events: Number (%) of Patients|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.